Participate in Share Chat. Set up virtual watchlists and portfolios See more trades and share info.
Register for FREE Now
Indivior topped the risers despite pre-tax profit dipping in the first quarter, as its RBP-7000 schizophrenia drug met the primary and secondary endpo...
Create a free LSE account to:
Already have an account? Sign In
Don't have an account? Register for FREE